Industry Research Reports

Home > Reports > Medical Care > Granulocyte-Colony Stimulating Factor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Granulocyte-Colony Stimulating Factor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 92 Pages

Report ld: 2342657

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Granulocyte-Colony Stimulating Factor was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Granulocyte-Colony Stimulating Factor was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Granulocyte-Colony Stimulating Factor was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Granulocyte-Colony Stimulating Factor was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Granulocyte-Colony Stimulating Factor include BioCad, Dong-A Socio Group, Pfizer, Intas Pharmaceuticals, Novartis AG, Stada Arzneimittel, Teva Pharmaceutical Industries, Amgen and Dr. Reddy's Laboratories, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Granulocyte-Colony Stimulating Factor, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Granulocyte-Colony Stimulating Factor by region & country, by Type, and by Application.

The Granulocyte-Colony Stimulating Factor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Granulocyte-Colony Stimulating Factor.

Market Segmentation

Report Metric
Details
Report Title
Granulocyte-Colony Stimulating Factor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Granulocyte-Colony Stimulating Factor Companies Covered
BioCad, Dong-A Socio Group, Pfizer, Intas Pharmaceuticals, Novartis AG, Stada Arzneimittel, Teva Pharmaceutical Industries, Amgen, Dr. Reddy's Laboratories
Global Granulocyte-Colony Stimulating Factor Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Granulocyte-Colony Stimulating Factor Market, Segment by Type
Capsules

Tablets

Others
Global Granulocyte-Colony Stimulating Factor Market, Segment by Application
Oncological Diseases

Blood Disorders

Growth Hormone Deficiencies

Chronic and Autoimmune Disorders

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Granulocyte-Colony Stimulating Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Granulocyte-Colony Stimulating Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Granulocyte-Colony Stimulating Factor in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Granulocyte-Colony Stimulating Factor Product Introduction
    1.2 Global Granulocyte-Colony Stimulating Factor Market Size Forecast
        1.2.1 Global Granulocyte-Colony Stimulating Factor Sales Value (2019-2030)
        1.2.2 Global Granulocyte-Colony Stimulating Factor Sales Volume (2019-2030)
        1.2.3 Global Granulocyte-Colony Stimulating Factor Sales Price (2019-2030)
    1.3 Granulocyte-Colony Stimulating Factor Market Trends & Drivers
        1.3.1 Granulocyte-Colony Stimulating Factor Industry Trends
        1.3.2 Granulocyte-Colony Stimulating Factor Market Drivers & Opportunity
        1.3.3 Granulocyte-Colony Stimulating Factor Market Challenges
        1.3.4 Granulocyte-Colony Stimulating Factor Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Granulocyte-Colony Stimulating Factor Players Revenue Ranking (2023)
    2.2 Global Granulocyte-Colony Stimulating Factor Revenue by Company (2019-2024)
    2.3 Global Granulocyte-Colony Stimulating Factor Players Sales Volume Ranking (2023)
    2.4 Global Granulocyte-Colony Stimulating Factor Sales Volume by Company Players (2019-2024)
    2.5 Global Granulocyte-Colony Stimulating Factor Average Price by Company (2019-2024)
    2.6 Key Manufacturers Granulocyte-Colony Stimulating Factor Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Granulocyte-Colony Stimulating Factor Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Granulocyte-Colony Stimulating Factor
    2.9 Granulocyte-Colony Stimulating Factor Market Competitive Analysis
        2.9.1 Granulocyte-Colony Stimulating Factor Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Granulocyte-Colony Stimulating Factor Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Granulocyte-Colony Stimulating Factor as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Capsules
        3.1.2 Tablets
        3.1.3 Others
    3.2 Global Granulocyte-Colony Stimulating Factor Sales Value by Type
        3.2.1 Global Granulocyte-Colony Stimulating Factor Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Granulocyte-Colony Stimulating Factor Sales Value, by Type (2019-2030)
        3.2.3 Global Granulocyte-Colony Stimulating Factor Sales Value, by Type (%) (2019-2030)
    3.3 Global Granulocyte-Colony Stimulating Factor Sales Volume by Type
        3.3.1 Global Granulocyte-Colony Stimulating Factor Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Granulocyte-Colony Stimulating Factor Sales Volume, by Type (2019-2030)
        3.3.3 Global Granulocyte-Colony Stimulating Factor Sales Volume, by Type (%) (2019-2030)
    3.4 Global Granulocyte-Colony Stimulating Factor Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Oncological Diseases
        4.1.2 Blood Disorders
        4.1.3 Growth Hormone Deficiencies
        4.1.4 Chronic and Autoimmune Disorders
        4.1.5 Others
    4.2 Global Granulocyte-Colony Stimulating Factor Sales Value by Application
        4.2.1 Global Granulocyte-Colony Stimulating Factor Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Granulocyte-Colony Stimulating Factor Sales Value, by Application (2019-2030)
        4.2.3 Global Granulocyte-Colony Stimulating Factor Sales Value, by Application (%) (2019-2030)
    4.3 Global Granulocyte-Colony Stimulating Factor Sales Volume by Application
        4.3.1 Global Granulocyte-Colony Stimulating Factor Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Granulocyte-Colony Stimulating Factor Sales Volume, by Application (2019-2030)
        4.3.3 Global Granulocyte-Colony Stimulating Factor Sales Volume, by Application (%) (2019-2030)
    4.4 Global Granulocyte-Colony Stimulating Factor Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Granulocyte-Colony Stimulating Factor Sales Value by Region
        5.1.1 Global Granulocyte-Colony Stimulating Factor Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Granulocyte-Colony Stimulating Factor Sales Value by Region (2019-2024)
        5.1.3 Global Granulocyte-Colony Stimulating Factor Sales Value by Region (2025-2030)
        5.1.4 Global Granulocyte-Colony Stimulating Factor Sales Value by Region (%), (2019-2030)
    5.2 Global Granulocyte-Colony Stimulating Factor Sales Volume by Region
        5.2.1 Global Granulocyte-Colony Stimulating Factor Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Granulocyte-Colony Stimulating Factor Sales Volume by Region (2019-2024)
        5.2.3 Global Granulocyte-Colony Stimulating Factor Sales Volume by Region (2025-2030)
        5.2.4 Global Granulocyte-Colony Stimulating Factor Sales Volume by Region (%), (2019-2030)
    5.3 Global Granulocyte-Colony Stimulating Factor Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        5.4.2 North America Granulocyte-Colony Stimulating Factor Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        5.5.2 Europe Granulocyte-Colony Stimulating Factor Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        5.6.2 Asia Pacific Granulocyte-Colony Stimulating Factor Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        5.7.2 South America Granulocyte-Colony Stimulating Factor Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        5.8.2 Middle East & Africa Granulocyte-Colony Stimulating Factor Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Value
        6.2.1 Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        6.3.2 United States Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Granulocyte-Colony Stimulating Factor Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        6.4.2 Europe Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Granulocyte-Colony Stimulating Factor Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        6.5.2 China Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Granulocyte-Colony Stimulating Factor Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        6.6.2 Japan Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Granulocyte-Colony Stimulating Factor Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        6.7.2 South Korea Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Granulocyte-Colony Stimulating Factor Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        6.8.2 Southeast Asia Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Granulocyte-Colony Stimulating Factor Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Granulocyte-Colony Stimulating Factor Sales Value, 2019-2030
        6.9.2 India Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Granulocyte-Colony Stimulating Factor Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 BioCad
        7.1.1 BioCad Company Information
        7.1.2 BioCad Introduction and Business Overview
        7.1.3 BioCad Granulocyte-Colony Stimulating Factor Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 BioCad Granulocyte-Colony Stimulating Factor Product Offerings
        7.1.5 BioCad Recent Development
    7.2 Dong-A Socio Group
        7.2.1 Dong-A Socio Group Company Information
        7.2.2 Dong-A Socio Group Introduction and Business Overview
        7.2.3 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Product Offerings
        7.2.5 Dong-A Socio Group Recent Development
    7.3 Pfizer
        7.3.1 Pfizer Company Information
        7.3.2 Pfizer Introduction and Business Overview
        7.3.3 Pfizer Granulocyte-Colony Stimulating Factor Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Pfizer Granulocyte-Colony Stimulating Factor Product Offerings
        7.3.5 Pfizer Recent Development
    7.4 Intas Pharmaceuticals
        7.4.1 Intas Pharmaceuticals Company Information
        7.4.2 Intas Pharmaceuticals Introduction and Business Overview
        7.4.3 Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Product Offerings
        7.4.5 Intas Pharmaceuticals Recent Development
    7.5 Novartis AG
        7.5.1 Novartis AG Company Information
        7.5.2 Novartis AG Introduction and Business Overview
        7.5.3 Novartis AG Granulocyte-Colony Stimulating Factor Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Novartis AG Granulocyte-Colony Stimulating Factor Product Offerings
        7.5.5 Novartis AG Recent Development
    7.6 Stada Arzneimittel
        7.6.1 Stada Arzneimittel Company Information
        7.6.2 Stada Arzneimittel Introduction and Business Overview
        7.6.3 Stada Arzneimittel Granulocyte-Colony Stimulating Factor Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Stada Arzneimittel Granulocyte-Colony Stimulating Factor Product Offerings
        7.6.5 Stada Arzneimittel Recent Development
    7.7 Teva Pharmaceutical Industries
        7.7.1 Teva Pharmaceutical Industries Company Information
        7.7.2 Teva Pharmaceutical Industries Introduction and Business Overview
        7.7.3 Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Product Offerings
        7.7.5 Teva Pharmaceutical Industries Recent Development
    7.8 Amgen
        7.8.1 Amgen Company Information
        7.8.2 Amgen Introduction and Business Overview
        7.8.3 Amgen Granulocyte-Colony Stimulating Factor Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Amgen Granulocyte-Colony Stimulating Factor Product Offerings
        7.8.5 Amgen Recent Development
    7.9 Dr. Reddy's Laboratories
        7.9.1 Dr. Reddy's Laboratories Company Information
        7.9.2 Dr. Reddy's Laboratories Introduction and Business Overview
        7.9.3 Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Product Offerings
        7.9.5 Dr. Reddy's Laboratories Recent Development

 8 Industry Chain Analysis
    8.1 Granulocyte-Colony Stimulating Factor Industrial Chain
    8.2 Granulocyte-Colony Stimulating Factor Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Granulocyte-Colony Stimulating Factor Sales Model
        8.5.2 Sales Channel
        8.5.3 Granulocyte-Colony Stimulating Factor Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Granulocyte-Colony Stimulating Factor Market Trends
    Table 2. Granulocyte-Colony Stimulating Factor Market Drivers & Opportunity
    Table 3. Granulocyte-Colony Stimulating Factor Market Challenges
    Table 4. Granulocyte-Colony Stimulating Factor Market Restraints
    Table 5. Global Granulocyte-Colony Stimulating Factor Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Granulocyte-Colony Stimulating Factor Revenue Market Share by Company (2019-2024)
    Table 7. Global Granulocyte-Colony Stimulating Factor Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Granulocyte-Colony Stimulating Factor Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Granulocyte-Colony Stimulating Factor Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Granulocyte-Colony Stimulating Factor Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Granulocyte-Colony Stimulating Factor Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Granulocyte-Colony Stimulating Factor
    Table 13. Global Granulocyte-Colony Stimulating Factor Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Granulocyte-Colony Stimulating Factor as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Granulocyte-Colony Stimulating Factor Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Granulocyte-Colony Stimulating Factor Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Granulocyte-Colony Stimulating Factor Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Granulocyte-Colony Stimulating Factor Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Granulocyte-Colony Stimulating Factor Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Granulocyte-Colony Stimulating Factor Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Granulocyte-Colony Stimulating Factor Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Granulocyte-Colony Stimulating Factor Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Granulocyte-Colony Stimulating Factor Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Granulocyte-Colony Stimulating Factor Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Granulocyte-Colony Stimulating Factor Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Granulocyte-Colony Stimulating Factor Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Granulocyte-Colony Stimulating Factor Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Granulocyte-Colony Stimulating Factor Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Granulocyte-Colony Stimulating Factor Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Granulocyte-Colony Stimulating Factor Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Granulocyte-Colony Stimulating Factor Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Granulocyte-Colony Stimulating Factor Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Granulocyte-Colony Stimulating Factor Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Granulocyte-Colony Stimulating Factor Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Granulocyte-Colony Stimulating Factor Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Granulocyte-Colony Stimulating Factor Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Granulocyte-Colony Stimulating Factor Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Granulocyte-Colony Stimulating Factor Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Granulocyte-Colony Stimulating Factor Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Granulocyte-Colony Stimulating Factor Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Granulocyte-Colony Stimulating Factor Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Granulocyte-Colony Stimulating Factor Sales Value by Region (2019-2024) & (%)
    Table 44. Global Granulocyte-Colony Stimulating Factor Sales Value by Region (2025-2030) & (%)
    Table 45. Global Granulocyte-Colony Stimulating Factor Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Granulocyte-Colony Stimulating Factor Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Granulocyte-Colony Stimulating Factor Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Granulocyte-Colony Stimulating Factor Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Granulocyte-Colony Stimulating Factor Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Granulocyte-Colony Stimulating Factor Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Granulocyte-Colony Stimulating Factor Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Volume, (2025-2030) & (K Units)
    Table 57. BioCad Company Information
    Table 58. BioCad Introduction and Business Overview
    Table 59. BioCad Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. BioCad Granulocyte-Colony Stimulating Factor Product Offerings
    Table 61. BioCad Recent Development
    Table 62. Dong-A Socio Group Company Information
    Table 63. Dong-A Socio Group Introduction and Business Overview
    Table 64. Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Dong-A Socio Group Granulocyte-Colony Stimulating Factor Product Offerings
    Table 66. Dong-A Socio Group Recent Development
    Table 67. Pfizer Company Information
    Table 68. Pfizer Introduction and Business Overview
    Table 69. Pfizer Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Pfizer Granulocyte-Colony Stimulating Factor Product Offerings
    Table 71. Pfizer Recent Development
    Table 72. Intas Pharmaceuticals Company Information
    Table 73. Intas Pharmaceuticals Introduction and Business Overview
    Table 74. Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Product Offerings
    Table 76. Intas Pharmaceuticals Recent Development
    Table 77. Novartis AG Company Information
    Table 78. Novartis AG Introduction and Business Overview
    Table 79. Novartis AG Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Novartis AG Granulocyte-Colony Stimulating Factor Product Offerings
    Table 81. Novartis AG Recent Development
    Table 82. Stada Arzneimittel Company Information
    Table 83. Stada Arzneimittel Introduction and Business Overview
    Table 84. Stada Arzneimittel Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Stada Arzneimittel Granulocyte-Colony Stimulating Factor Product Offerings
    Table 86. Stada Arzneimittel Recent Development
    Table 87. Teva Pharmaceutical Industries Company Information
    Table 88. Teva Pharmaceutical Industries Introduction and Business Overview
    Table 89. Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Product Offerings
    Table 91. Teva Pharmaceutical Industries Recent Development
    Table 92. Amgen Company Information
    Table 93. Amgen Introduction and Business Overview
    Table 94. Amgen Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Amgen Granulocyte-Colony Stimulating Factor Product Offerings
    Table 96. Amgen Recent Development
    Table 97. Dr. Reddy's Laboratories Company Information
    Table 98. Dr. Reddy's Laboratories Introduction and Business Overview
    Table 99. Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Product Offerings
    Table 101. Dr. Reddy's Laboratories Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Granulocyte-Colony Stimulating Factor Downstream Customers
    Table 105. Granulocyte-Colony Stimulating Factor Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Granulocyte-Colony Stimulating Factor Product Picture
    Figure 2. Global Granulocyte-Colony Stimulating Factor Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Granulocyte-Colony Stimulating Factor Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Granulocyte-Colony Stimulating Factor Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Granulocyte-Colony Stimulating Factor Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Granulocyte-Colony Stimulating Factor Report Years Considered
    Figure 7. Global Granulocyte-Colony Stimulating Factor Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Granulocyte-Colony Stimulating Factor Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Granulocyte-Colony Stimulating Factor Revenue in 2023
    Figure 10. Granulocyte-Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Capsules Picture
    Figure 12. Tablets Picture
    Figure 13. Others Picture
    Figure 14. Global Granulocyte-Colony Stimulating Factor Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Granulocyte-Colony Stimulating Factor Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Granulocyte-Colony Stimulating Factor Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Granulocyte-Colony Stimulating Factor Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Granulocyte-Colony Stimulating Factor Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Oncological Diseases
    Figure 20. Product Picture of Blood Disorders
    Figure 21. Product Picture of Growth Hormone Deficiencies
    Figure 22. Product Picture of Chronic and Autoimmune Disorders
    Figure 23. Product Picture of Others
    Figure 24. Global Granulocyte-Colony Stimulating Factor Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Granulocyte-Colony Stimulating Factor Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Granulocyte-Colony Stimulating Factor Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Granulocyte-Colony Stimulating Factor Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Granulocyte-Colony Stimulating Factor Price by Application (2019-2030) & (US$/Unit)
    Figure 29. North America Granulocyte-Colony Stimulating Factor Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Granulocyte-Colony Stimulating Factor Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Granulocyte-Colony Stimulating Factor Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Granulocyte-Colony Stimulating Factor Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Granulocyte-Colony Stimulating Factor Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Granulocyte-Colony Stimulating Factor Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Granulocyte-Colony Stimulating Factor Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Granulocyte-Colony Stimulating Factor Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Granulocyte-Colony Stimulating Factor Sales Volume (%), (2019-2030)
    Figure 41. United States Granulocyte-Colony Stimulating Factor Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Granulocyte-Colony Stimulating Factor Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Granulocyte-Colony Stimulating Factor Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Granulocyte-Colony Stimulating Factor Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Granulocyte-Colony Stimulating Factor Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Granulocyte-Colony Stimulating Factor Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Granulocyte-Colony Stimulating Factor Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Granulocyte-Colony Stimulating Factor Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Granulocyte-Colony Stimulating Factor Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Granulocyte-Colony Stimulating Factor Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Granulocyte-Colony Stimulating Factor Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Granulocyte-Colony Stimulating Factor Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Granulocyte-Colony Stimulating Factor Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Granulocyte-Colony Stimulating Factor Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Granulocyte-Colony Stimulating Factor Sales Value by Application (%), 2023 VS 2030
    Figure 62. Granulocyte-Colony Stimulating Factor Industrial Chain
    Figure 63. Granulocyte-Colony Stimulating Factor Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Description

The global market for Granulocyte-Colony Stimulating Factor was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Granulocyte-Colony Stimulating Factor was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Granulocyte-Colony Stimulating Factor was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Granulocyte-Colony Stimulating Factor was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Granulocyte-Colony Stimulating Factor include BioCad, Dong-A Socio Group, Pfizer, Intas Pharmaceuticals, Novartis AG, Stada Arzneimittel, Teva Pharmaceutical Industries, Amgen and Dr. Reddy's Laboratories, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Granulocyte-Colony Stimulating Factor, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Granulocyte-Colony Stimulating Factor by region & country, by Type, and by Application.

The Granulocyte-Colony Stimulating Factor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Granulocyte-Colony Stimulating Factor.

Market Segmentation